It seems so unlikely they would have any real Value medicinally over the dozens of other more abundant compounds in cannabis that reduce inflammation.
Weed is what it is because it gets you high, we all fell in love with, atleast I would think, because it gets you stoned. Shouldn’t be be focused on the compounds responsible for those effects, not red herring novel molecules that one can market as the next best thing.
Amywazwaz06@gmail.com. I own several
Retail smoke shops in Midwest and the south. D8 is flying out the door. I am very interested in new stuff. Customers are now willing to try new variations. I would love to
Work with someone who wants to go down that path. You have to be willing to take the risks. We are.
The good cannabinoid products are dominant in THC for regulated markets or pharma imho. I think people are wasting their time and money with CBN until big co-mans create stock formulas that actually work. And CBN iso alone in tinctures, caps, gummies, aint it. The minor cannabinoid, next big thing hype is over with N. You are trying to sell a “sedating” chemical yet you can’t legally make biological modulating claims such as “sedating” on it. Doesn’t sound very logical or lucrative…